Pamela T. Soliman MD(@PamSolimanMD) 's Twitter Profileg
Pamela T. Soliman MD

@PamSolimanMD

Gynecologic Oncologist @MDAndersonNews specializing in #endometrialcancer, #ovariancanver, #cervixcancer. Tweets are my own. #endcancer

ID:977903382638841857

linkhttps://faculty.mdanderson.org/profiles/pamela_soliman.html calendar_today25-03-2018 13:41:49

711 Tweets

1,8K Followers

481 Following

Follow People
Ovarcome(@ovarcome) 's Twitter Profile Photo

Kudos to Co-Chairs Dr. Anil Sood and Dr. Karen Lu for a memorable event once again! Many memories, ONE mission. Together We Ovarcome Ovarian Cancer!

Kudos to Co-Chairs Dr. @AnilSoodMD and Dr. @karenluMD for a memorable event once again! Many memories, ONE mission. Together We Ovarcome Ovarian Cancer! #SprintForLife24
account_circle
MD Anderson Cancer Center(@MDAndersonNews) 's Twitter Profile Photo

Symptoms of ovarian cancer can be vague and mistaken for other conditions.

Here, our Dr. Pamela Soliman shares how to recognize the signs: brnw.ch/21wJfXZ Pamela T. Soliman MD

account_circle
Ginger J. Gardner(@ggardnermd) 's Twitter Profile Photo

Huge Opportunity for emerging clinical trialists, career development and research!! Time to spread the exciting news👍🎉Applications to participate in BRIDGES 2.0 being received until May 16! Shannon Westin, MD, MPH, FASCO Eric Rios-Doria, MD Gregg Nelson

account_circle
MD Anderson Cancer Center(@MDAndersonNews) 's Twitter Profile Photo

When pain lingers for more than two weeks and won’t go away with medication, that’s a big red flag, says our Dr. Pamela Soliman.

Learn about ovarian cancer pain and when to see your doctor: brnw.ch/21wILUm Pamela T. Soliman MD

account_circle
Shannon Westin, MD, MPH, FASCO(@ShannonWestin) 's Twitter Profile Photo

🤔Analysis of the GOG258 trial results in based on TCGA classifiers is intriguing...
Improvement in RFS for p53wt treated with chemoradiation as opposed to chemotherapy, however, no apparent benefit w/ radiation therapy in MMRd

🤔Analysis of the GOG258 trial results in #EndometrialCancer based on TCGA classifiers is intriguing... Improvement in RFS for p53wt treated with chemoradiation as opposed to chemotherapy, however, no apparent benefit w/ radiation therapy in MMRd #SGOMtg #gyncsm #radonc
account_circle
Naomi Adjei, MD, MPH, MSEd(@Naomi_AdjeiMD) 's Twitter Profile Photo

Your legacy is for life! Thank you for making room for all of us! Your bravery, vulnerability and generosity have inspired me. Thank you Dr. Frumovitz MD Anderson Cancer Center SGO

Your legacy is for life! Thank you for making room for all of us! Your bravery, vulnerability and generosity have inspired me. Thank you Dr. Frumovitz @MDAndersonNews @SGO_org #SGO2024
account_circle
Nicole D. Fleming MD(@nicoleflemingmd) 's Twitter Profile Photo

Congrats to our fellow Dr Huepenbecker on her poster presentation SGO evaluating outcomes of traditional ERAS pathways in patients undergoing pelvic exenteration in Gyn cancers MD Anderson Cancer Center

Congrats to our fellow Dr Huepenbecker on her poster presentation @SGO_org evaluating outcomes of traditional ERAS pathways in patients undergoing pelvic exenteration in Gyn cancers @MDAndersonNews #SGOMtg #gyncsm #oncsurgery
account_circle
Naomi Adjei, MD, MPH, MSEd(@Naomi_AdjeiMD) 's Twitter Profile Photo

Ovarian cancer is deadly, costly, and impacts overall QOL. Primary prevention via opportunistic salpingectomy is cost-effective and safe. Thanks to my mentors and SGO for the opportunity to discuss our work. 📸Dana Hazimeh

Ovarian cancer is deadly, costly, and impacts overall QOL. Primary prevention via opportunistic salpingectomy is cost-effective and safe. Thanks to my mentors and @SGO_org for the opportunity to discuss our work. #SGO2024 📸@danahazime1
account_circle
Anne Knisely, MD(@AnneKniselyMD) 's Twitter Profile Photo

Incredibly proud of my ⭐️ co-fellow Amma Asare for presenting her research on factors associated with therapy related myeloid neoplasms (t-MN) in patients with ovarian cancer treated with PARP inhibitors. We must balance risks and benefits of PARPi ⚖️ MD Anderson Cancer Center Anil Sood

Incredibly proud of my ⭐️ co-fellow Amma Asare for presenting her research on factors associated with therapy related myeloid neoplasms (t-MN) in patients with ovarian cancer treated with PARP inhibitors. We must balance risks and benefits of PARPi ⚖️ @MDAndersonNews @AnilSoodMD
account_circle